Search Results

1 - 10 of 82
Staff
Dr. Charles Venditti is a senior investigator in NHGRI's Center for Precision Health Research.
… Dr. Charles P. Venditti received a S.B. from the Massachusetts Institute of … … Organic Acid Research Section Staff … Related Projects … Charles P. Venditti, M.D., Ph.D. … Dr. Charles Venditti is a …
News Release
NHGRI has selected Charles Venditti, M.D., Ph.D., as chief of its Metabolic Medicine Branch within the Institute’s Intramural Research Program. In this role, he will provide leadership and guidance on research into genetic diseases that disrupt metabolism.
Venditti to provide leadership for clinical and laboratory … of the National Institutes of Health (NIH), has selected Charles P. Venditti, M.D., Ph.D., as chief of its Metabolic … and clinical aspects of metabolic diseases,” said Charles Rotimi, Ph.D., NHGRI scientific director. “He has …
Staff
Dr. Charles Rotimi is the scientific director of and NIH Distinguished Investigator in the Division of Intramural Research. He also serves as the director of the Center for Research on Genomics and Global Health (CRGGH).
… … Scientific Summary … Publications … Related Projects … Charles N. Rotimi, Ph.D. … Dr. Charles Rotimi is the scientific director of and NIH … for Research on Genomics and Global Health (CRGGH). … Charles Rotimi, Center for Research on Genomics and Global …
News Release
Researchers have discovered that FGF21 is elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia.
… into health care treatment, but not in this case," said Charles P. Venditti , M.D., Ph.D., senior author and senior investigator … medical genomics, genetic disorders, gene therapy, Charles Venditti … Researchers have discovered that FGF21 is …
The Genomics Landscape
In the October 2021 issue of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., introduces us to new scientific director Charles Rotimi, Ph.D., his background and prior accomplishments.
… Moderator: Chris Gunter, Ph.D., NHGRI …   Later this week, Charles Rotimi, Ph.D., will take the helm as the NHGRI … and leader of the NHGRI Intramural Research Program . Charles is a long-standing member of the NHGRI Intramural … Cardiovascular, and Inflammatory Disease Genomics Branch. Charles has designed and led major basic science and clinical …
News Release
NHGRI has selected Charles Rotimi, Ph.D., as the next scientific director. In this role, he will lead the institute’s Intramural Research Program, which conducts basic and clinical research to enable a greater understanding of human disease and to develop better methods to detect, prevent and treat genetic disorders.
… Human Genome Research Institute (NHGRI) has selected Charles Rotimi, Ph.D., as the next scientific director. In … and in the international scientific workforce. “Charles is a highly accomplished human geneticist and … spectrum of genomics research,” Dr. Green said. “With Charles’ extensive leadership within the program, ability to …
News Release
Charles Rotimi, Ph.D., has been presented with the 2018 HudsonAlpha Life Sciences Prize from the HudsonAlpha Institute for Biotechnology
… Research on Genomics and Global Health (CRGGH) Director Charles Rotimi, Ph.D., has been presented with the 2018 … a Critical Need for Diversity Richard Myers (left) and Charles Rotimi This prize is given to honor life sciences … will serve all humanity." … Related Content … Dr. Charles Rotimi receives HudsonAlpha Life Sciences Prize … …
News Release
NIH researchers demonstrated that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1.
… for gene therapy as a treatment for NPC1 disease," said Charles P. Venditti, M.D., Ph.D., senior investigator in the NHGRI … disease, gene therapy, NPC1 gene, William Pavan, Charles Venditti … NIH researchers demonstrated that gene …
News Release
The Physician-Scientist Development Program helps physicians develop research programs dedicated to the disorders they specialize in.
… "The clinical problems are close enough at hand." Charles Venditti, M.D., Ph.D., himself an alumnus of the program, is … programs, Peter McGuire M.D., Leslie Biesecker M.D., Charles Venditti, M.D. Ph.D. … The Physician-Scientist …
News Release
NIH researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy.
… therapy we have developed so far to treat MMA," said Charles Venditti, M.D., Ph.D., senior author and investigator in … adeno-associated virus, AAV, methylmalonic acidemia, MMA, Charles Venditti M.D. Ph.D., AAV and liver cancer … NIH …